Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT01141751
Eligibility Criteria:
Inclusion Criteria:
* Subjects eligible for Rebif therapy according to indications and clinical use in the Rebif Product Monograph (and subject who agreed to start on Rebif therapy)
* Subjects who have read, understood, signed and dated the informed consent form
Exclusion Criteria:
* Subjects who are unable to fill in the questionnaires by him/herself
* Subjects who have used disease modifying drugs within the last month (or 30 days) prior to study Day 1
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01141751
Study Brief:
Protocol Section:
NCT01141751